Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sargent, DJ
  • Marsoni, S
  • Thibodeau, SN
  • Labianca, R
  • Hamilton, SR
  • Torri, V
  • Monges, G
  • Ribic, Christine
  • Grothey, A
  • Gallinger, S

publication date

  • May 20, 2008